Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Risk factors for COVID-19-related in-hospital mortality in a high HIV and tuberculosis prevalence setting in South Africa: a cohort study
Waasila Jassat, Cheryl Cohen, Stefano Tempia, et al.
The Lancet HIV (2021) Vol. 8, Iss. 9, pp. e554-e567
Open Access | Times Cited: 154

Showing 1-25 of 154 citing articles:

Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa: a data linkage study
Nicole Wolter, Waasila Jassat, Sibongile Walaza, et al.
The Lancet (2022) Vol. 399, Iss. 10323, pp. 437-446
Open Access | Times Cited: 635
The intersecting pandemics of tuberculosis and COVID-19: population-level and patient-level impact, clinical presentation, and corrective interventions
Keertan Dheda, Tahlia Perumal, Harry Moultrie, et al.
The Lancet Respiratory Medicine (2022) Vol. 10, Iss. 6, pp. 603-622
Open Access | Times Cited: 194
Clinical features of, and risk factors for, severe or fatal COVID-19 among people living with HIV admitted to hospital: analysis of data from the WHO Global Clinical Platform of COVID-19
Silvia Bertagnolio, Soe Soe Thwin, Ronaldo Silva, et al.
The Lancet HIV (2022) Vol. 9, Iss. 7, pp. e486-e495
Open Access | Times Cited: 137
Early assessment of the clinical severity of the SARS-CoV-2 Omicron variant in South Africa
Nicole Wolter, Waasila Jassat, Sibongile Walaza, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 122
Clinical severity of SARS-CoV-2 Omicron BA.4 and BA.5 lineages compared to BA.1 and Delta in South Africa
Nicole Wolter, Waasila Jassat, Sibongile Walaza, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 86
Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19
Christiana Kartsonaki, J. Kenneth Baillie, Noelia García Barrio, et al.
International Journal of Epidemiology (2023) Vol. 52, Iss. 2, pp. 355-376
Open Access | Times Cited: 46
The COVID-19 and TB syndemic: the way forward
Anete Trajman, Irina Felker, Layana Costa Alves, et al.
The International Journal of Tuberculosis and Lung Disease (2022) Vol. 26, Iss. 8, pp. 710-719
Open Access | Times Cited: 53
Immunogenicity and safety of a SARS-CoV-2 recombinant spike protein nanoparticle vaccine in people living with and without HIV-1 infection: a randomised, controlled, phase 2A/2B trial
Shabir A. Madhi, Dhayendre Moodley, Sherika Hanley, et al.
The Lancet HIV (2022) Vol. 9, Iss. 5, pp. e309-e322
Open Access | Times Cited: 49
Clinical severity of omicron lineage BA.2 infection compared with BA.1 infection in South Africa
Nicole Wolter, Waasila Jassat, Anne von Gottberg, et al.
The Lancet (2022) Vol. 400, Iss. 10346, pp. 93-96
Open Access | Times Cited: 48
Prolonged Shedding of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at High Viral Loads Among Hospitalized Immunocompromised Persons Living With Human Immunodeficiency Virus (HIV), South Africa
Susan Meiring, Stefano Tempia, Jinal N. Bhiman, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. 1, pp. e144-e156
Open Access | Times Cited: 47
The impact of COVID-19 on communicable and non-communicable diseases in Africa: a narrative review
Beatrice Formenti, Natalia Gregori, Verena Crosato, et al.
Infezioni in Medicina (2022) Vol. 30, Iss. 1
Open Access | Times Cited: 40
Effects of tuberculosis and/or HIV-1 infection on COVID-19 presentation and immune response in Africa
Elsa Du Bruyn, Cari Stek, Remi Daroowala, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 29
Reactivation of Kaposi’s sarcoma-associated herpesvirus (KSHV) by SARS-CoV-2 in non-hospitalised HIV-infected patients
Humaira Lambarey, Melissa J. Blumenthal, Abeen Chetram, et al.
EBioMedicine (2024) Vol. 100, pp. 104986-104986
Open Access | Times Cited: 9
Africa: tackle HIV and COVID-19 together
Nokukhanya Msomi, Richard Lessells, Koleka Mlisana, et al.
Nature (2021) Vol. 600, Iss. 7887, pp. 33-36
Closed Access | Times Cited: 50
HIV status alters disease severity and immune cell responses in Beta variant SARS-CoV-2 infection wave
Farina Karim, Inbal Gazy, Sandile Cele, et al.
eLife (2021) Vol. 10
Open Access | Times Cited: 41
Systematic Review and Meta-Analyses of The Interaction Between HIV Infection And COVID-19: Two Years’ Evidence Summary
Yehua Wang, Yewei Xie, Siyue Hu, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33
Risk of mortality in HIV-infected COVID-19 patients: A systematic review and meta-analysis
Tafadzwa Dzinamarira, Grant Murewanhema, Itai Chitungo, et al.
Journal of Infection and Public Health (2022) Vol. 15, Iss. 6, pp. 654-661
Open Access | Times Cited: 29
COVID-19 and Tuberculosis: Unveiling the Dual Threat and Shared Solutions Perspective
Ramona Cioboată, Viorel Biciușcă, Mihai Olteanu, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 14, pp. 4784-4784
Open Access | Times Cited: 17
The COVID-19, tuberculosis and HIV/AIDS: Ménage à Trois
Aniefiok John Udoakang, Alexandra Lindsey Djomkam Zune, Kesego Tapela, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 15
Theoretical and mathematical codynamics of nonlinear tuberculosis and COVID-19 model pertaining to fractional calculus and probabilistic approach
Saima Rashid, Sher Zaman Hamidi, Saima Akram, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Risk of SARS-CoV-2 infection and adverse outcomes among vaccinated patients with tuberculosis
Renin Chang, Sheng-Yin Chen, Tina Yi Jin Hsieh, et al.
Public Health (2025) Vol. 239, pp. 80-86
Closed Access
Mycobacterium tuberculosis growth inhibition by peripheral blood mononuclear cells from household contacts is not affected by previous SARS-CoV-2 infection
Jane Shaw, Charlotte Christie Petersen, Andriëtte Hiemstra, et al.
(2025)
Closed Access
Mycobacterium tuberculosis growth inhibition by peripheral blood mononuclear cells from household contacts is not affected by previous SARS-CoV-2 infection
Jane Shaw, Charlotte Christie Petersen, Andriëtte Hiemstra, et al.
(2025)
Closed Access
Impact of the COVID-19 pandemic on tuberculosis control in Indonesia: a nationwide longitudinal analysis of programme data
Henry Surendra, Iqbal Elyazar, Evelyn Puspaningrum, et al.
The Lancet Global Health (2023) Vol. 11, Iss. 9, pp. e1412-e1421
Open Access | Times Cited: 13
Immune interaction between SARS-CoV-2 and Mycobacterium tuberculosis
Petro Booysen, Katalin A. Wilkinson, Dylan Sheerin, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top